4 Results for "

Necroptosis-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Necroptosis-IN-3" in MCE Product Catalog:

Cat. No.: HY-148454
CAS No.: 547698-18-0
Purity:  99.77%
Target:  

Necroptosis 11β-HSD

Research Areas:  

Inflammation/Immunology Cancer

Necroptosis-IN-3 (Compound 69) is a necroptosis inhibitor that inhibits TNF-α induced necroptosis . Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0244
CAS No.: 28543-07-9
Theaflavin-3'-gallate is a monomer of theaflavins found in black tea, which has anti-UVB damage activity and inhibits cell apoptosis and necroptosis. Theaflavin-3'-gallate acts as a pro-oxidant and induces oxidative stress in cancer cells, inhibiting xanthine oxidase (OX), with an IC50 of 7.6 μM [3].
loading...
    loading...
Cat. No.: HY-149393
CAS No.: 3052303-53-1
Purity:  95.98%
Research Areas:  

Cancer

RIPK3-IN-3 (compound 20) is a selective inhibitor of RIP kinase RIPK3 (IC50=10 nM). RIPK3 mediates the phosphorylation of Mixed Lineage Kinase (MLKL) and causes necroptosis, while RIPK3-IN-3 inhibits p-MLKL oligomerization and thereby inhibits necroptosis. RIPK3-IN-3 also downregulates CXCL5 secretion and inhibits AsPC-1 cell migration and invasion .
loading...
    loading...
Cat. No.: HY-189220
RIPK3-IN-8 is an orally active and selective RIPK3 inhibitor with a Kd of 150 nM. RIPK3-IN-8 disrupts the formation of the RIPK3-MLKL necrosome and reduces the phosphorylation of downstream MLKL. RIPK3-IN-8 inhibits necroptosis. RIPK3-IN-8 increases the survival rate in a mouse model of TNF-α/Z-VAD-fmk (HY-16658B)-induced systemic inflammatory response syndrome. RIPK3-IN-8 is used for the research of systemic inflammatory response syndrome .
loading...
    loading...